BROADCASTS.com

b'A three-drug combination sold under the brand name A three-drug combination sold under the brand name Trikafta Trikafta was approved by the was approved by the Food and Drug Administration Food and Drug Administration in October for people age 12 and older with cystic fibrosis. in October for people age 12 and older with cystic fibrosis. Christopher Fortner, MD, PhD Christopher Fortner, MD, PhD, medical director of the cystic fibrosis program at Upstate, describes how this treatment works, its side effects and what it may mean for many of the people with this disease. Cystic fibrosis causes persistent lung infections and limits the ability to breathe over time, among other problems., medical director of the cystic fibrosis program at Upstate, describes how this treatment works, its side effects and what it may mean for many of the people with this disease. Cystic fibrosis causes persistent lung infections and limits the ability to breathe over time, among other problems.'